DASATINIB TABLETS 70MG – Third Party Manufacturing

Medizia Biotech is a trusted pharmaceutical company offering Third Party Manufacturing of Dasatinib Tablets 70mg under stringent WHO-GMP compliant manufacturing standards. We provide high-quality oncology formulations with reliable manufacturing processes, ensuring consistent quality, safety, and regulatory compliance.

Dasatinib Tablets 70mg is an anti-cancer medicine belonging to the tyrosine kinase inhibitor (TKI) class. It is prescribed for the treatment of Philadelphia chromosome-positive (Ph+) Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL) under the supervision of qualified healthcare professionals.

Our third-party manufacturing services are designed for pharmaceutical companies, marketers, hospitals, government suppliers, exporters, and distributors seeking premium-quality oncology products. We support businesses with private labeling, custom packaging, bulk manufacturing, low MOQ (small batch manufacturing), and timely delivery to help them expand their product portfolio efficiently.

Our Third Party Manufacturing Features

• WHO-GMP compliant manufacturing facility
• Premium quality raw materials and strict quality control
• Private labeling and customized packaging
• Small batch and bulk manufacturing options
• Competitive pricing with timely delivery
• Regulatory documentation support
• PAN India supply and export support
• Dedicated customer support throughout the manufacturing process

Medizia Biotech is committed to delivering high-quality Dasatinib Tablets 70mg that meet national and international pharmaceutical standards. Whether you are launching a new oncology brand or expanding your existing portfolio, we provide dependable third-party manufacturing solutions tailored to your business requirements.